Eagle Pharmaceuticals (EGRX)

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2019 Results - Earnings Call Transcript
May 7, 2019 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q4 2018 Results - Earnings Call Transcript
Feb. 28, 2019 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals Inc. (EGRX) CEO Scott Tarriff on Q3 2018 Results - Earnings Call Transcript
Nov. 1, 2018 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals Inc. (EGRX) CEO Scott Tarriff on Q2 2018 Results - Earnings Call Transcript
Aug. 7, 2018 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2018 Results - Earnings Call Transcript
May 10, 2018 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q4 2017 Results - Earnings Call Transcript
Feb. 26, 2018 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q3 2017 Results - Earnings Call Transcript
Nov. 8, 2017 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q2 2017 Results - Earnings Call Transcript
Aug. 9, 2017 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2017 Results - Earnings Call Transcript
May 8, 2017 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q4 2016 Results - Earnings Call Transcript
March 1, 2017 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q3 2016 Results - Earnings Call Transcript
Nov. 9, 2016 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q2 2016 Results - Earnings Call Transcript
Aug. 9, 2016 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2016 Results - Earnings Call Transcript
May 9, 2016 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q4 2015 Results - Earnings Call Transcript
Feb. 25, 2016 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q3 2015 Results - Earnings Call Transcript
Nov. 11, 2015 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q2 2015 Results - Earnings Call Transcript
Aug. 11, 2015 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2015 Results - Earnings Call Transcript
May 18, 2015 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q4 2014 Results - Earnings Call Transcript
Dec. 17, 2014 | Price: Free! | Source: Seeking Alpha

Recent filings

Eagle Pharmaceuticals May 2019 © 2019 Eagle Pharmaceuticals, Inc. All Rights Reserved 1 - May 22, 2019

Douglas L. Braunstein just provided an update on activist position in Eagle Pharmaceuticals - May 14, 2019

Eagle Pharmaceuticals director just disposed of 159,223 shares - May 13, 2019

Eagle Pharmaceuticals May 2019 © 2019 Eagle Pharmaceuticals, Inc. All Rights Reserved 1 - May 8, 2019

Eagle Pharmaceuticals Just Filed Its Quarterly Report: Earnings Per Share B... - May 7, 2019

Eagle Pharmaceuticals, Inc. Reports First Quarter 2019 Results - May 7, 2019

Eagle Pharmaceuticals Announces Positive Results Of A Study Conducted In Partnership With The U.S. Military To Evaluate Neuroprotective Effects Of Ryanodex For The Treatment Of Nerve Agent Exposure - May 7, 2019

Other definitive proxy statements - April 30, 2019

Eagle: Soliciting Material Under §240.14A-12 Eagle Pharmaceuticals, Inc. - April 30, 2019

Eagle Pharmaceuticals, Inc. Expands Licensing Agreement For Bendeka™ With Teva Pharmaceuticals International Gmbh - April 15, 2019

Major owner of Eagle Pharmaceuticals just disposed of 24,975 shares - April 3, 2019

Eagle Pharmaceuticals director just picked up 2,340 shares - March 6, 2019

Eagle Pharmaceuticals director just picked up 2,136 shares - March 6, 2019

Eagle Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2018 Results - Feb. 28, 2019

Eagle Pharmaceuticals Just Filed Its Annual Report: Earnings Per ShareBa... - Feb. 28, 2019

Eagle Pharmaceuticals February 2019 © 2019 Eagle Pharmaceuticals, Inc. All Rights Reserved 1 - Feb. 21, 2019

Michael Graves just provided an update on share ownership of Eagle Pharmaceuticals - Feb. 14, 2019

STATE STREET CORPORATION just provided an update on share ownership of Eagle Pharmaceuticals - Feb. 14, 2019

Peter S. Park just provided an update on share ownership of Eagle Pharmaceuticals - Feb. 14, 2019

Janus Henderson Group plc EIN just provided an update on share ownership of Eagle Pharmaceuticals - Feb. 12, 2019

Major owner of Eagle Pharmaceuticals just disposed of 30,085 shares - Feb. 4, 2019

Victory Capital Management Inc. just provided an update on share ownership of Eagle Pharmaceuticals - Feb. 1, 2019

BlackRock, Inc. just provided an update on share ownership of Eagle Pharmaceuticals - Jan. 28, 2019

Eagle Pharmaceuticals director was just granted 10,000 options - Jan. 25, 2019

Major owner of Eagle Pharmaceuticals just picked up 61,300 shares - Jan. 25, 2019

Eagle Pharmaceuticals director was just granted 10,000 options - Jan. 25, 2019

Eagle Pharmaceuticals's EVP and Chief Medical Officer just picked up 18,229 shares - Jan. 25, 2019

Eagle Pharmaceuticals's Pres. & Chief Comm. Officer just picked up 20,042 shares - Jan. 25, 2019

Eagle Pharmaceuticals director was just granted 10,000 options - Jan. 25, 2019

Eagle Pharmaceuticals director was just granted 10,000 options - Jan. 25, 2019

Eagle Pharmaceuticals's Chief Financial Officer just picked up 18,700 shares - Jan. 25, 2019

Eagle Pharmaceuticals director was just granted 10,000 options - Jan. 25, 2019

Eagle Pharmaceuticals director was just granted 10,000 options - Jan. 25, 2019

Eagle Pharmaceuticals January 2019 © 2019 Eagle Pharmaceuticals, Inc. All Rights Reserved 1 - Jan. 7, 2019

Major owner of Eagle Pharmaceuticals just disposed of 31,569 shares - Jan. 4, 2019

Securities to be offered to employees in employee benefit plans - Dec. 18, 2018

Eagle Pharmaceuticals Announces Positive Results Of Pre-Clinical Study Conducted To Evaluate Effects Of Ryanodex In Acute Radiation Syndrome (Ars) - Nov. 27, 2018

Eagle Pharmaceuticals November 2018 Confidential © 2018 Eagle Pharmaceuticals, Inc. All Rights Reserved - Nov. 8, 2018

Eagle Pharmaceuticals, Inc. Reports Third Quarter 2018 Results - Nov. 1, 2018

Eagle Pharmaceuticals Announces Results Of Study For Fulvestrant - Oct. 30, 2018

Eagle Pharmaceuticals Commences $50 Million Accelerated Share Repurchase As Part Of New $150 Million Share Repurchase Authorization - Oct. 30, 2018

Eagle Pharmaceuticals October 2018 - Oct. 3, 2018

Eagle Pharmaceuticals Enters Into Agreement With Usamricd To Evaluate Neuroprotective Effects Of Ryanodex Secondary To Nerve Agent Exposure - Oct. 3, 2018

Departure of Directors or Certain - Sept. 26, 2018

Eagle Pharmaceuticals September 2018 - Sept. 13, 2018

Eagle Pharmaceuticals Concludes Enrollment Of Second Safety And Efficacy Study At Hajj To Evaluate Ryanodex For Exertional Heat Stroke - Aug. 30, 2018

Eagle Pharmaceuticals, Inc. Reports Second Quarter 2018 Results - Aug. 7, 2018

Eagle Pharmaceuticals Just Filed Its Quarterly Report: Earnings Per Share B... - Aug. 7, 2018

Fda Grants Eagle Seven Year Orphan Drug Exclusivity For Bendeka (Bendamustine Hydrochloride Injection) WOODCLIFF LAKE, N.J. - July 9, 2018

Submission of Matters to a Vote of Security - June 22, 2018

Court Issues Decision In Favor Of Eagle Pharmaceuticals Granting Seven Year Orphan Drug Exclusivity For - June 11, 2018

Eagle Pharmaceuticals, Inc. Granted Final Fda Approval For Bendamustine Hydrochloride Ready-To-Dilute Solution In A 500Ml Admixture - May 16, 2018

Eagle Pharmaceuticals, Inc. Reports First Quarter 2018 Results - May 10, 2018

Other definitive proxy statements - April 30, 2018

Eagle: Soliciting Material Under §240.14A-12 Eagle Pharmaceuticals, Inc. - April 30, 2018

Eagle Pharmaceuticals’ Vasopressin Anda Accepted For Filing By The Fda - April 16, 2018

Eagle Pharmaceuticals Announces New Patent For Eagle Biologics - March 28, 2018

Eagle Pharmaceuticals March 2018 - March 20, 2018

Eagle Pharmaceuticals March 2018 - March 7, 2018

Eagle Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2017 Results - Feb. 26, 2018

Departure of Directors or Certain - Feb. 22, 2018

Eagle Pharmaceuticals February 2018 - Feb. 21, 2018

Peter S. Park just provided an update on share ownership of Eagle Pharmaceuticals - Feb. 14, 2018

Michael Graves just provided an update on share ownership of Eagle Pharmaceuticals - Feb. 14, 2018

Janus Henderson Group plc EIN just provided an update on share ownership of Eagle Pharmaceuticals - Feb. 12, 2018

Victory Capital Management Inc. just provided an update on share ownership of Eagle Pharmaceuticals - Feb. 7, 2018

Departure of Directors or Certain - Jan. 30, 2018

Eagle Pharmaceuticals director was just granted 10,000 options - Jan. 9, 2018

Eagle Pharmaceuticals's Pres. & Chief Comm. Officer just picked up 10,000 shares - Jan. 9, 2018

Eagle Pharmaceuticals's EVP & Chief Scientific Officer just picked up 3,000 shares - Jan. 9, 2018

Eagle Pharmaceuticals director was just granted 10,000 options - Jan. 9, 2018

Eagle Pharmaceuticals's Chief Financial Officer just picked up 7,000 shares - Jan. 9, 2018

Eagle Pharmaceuticals director was just granted 10,000 options - Jan. 9, 2018

Eagle Pharmaceuticals director was just granted 10,000 options - Jan. 9, 2018

Eagle Pharmaceuticals's EVP and Chief Medical Officer just picked up 9,000 shares - Jan. 9, 2018

Eagle Pharmaceuticals director was just granted 10,000 options - Jan. 9, 2018

Eagle Pharmaceuticals's CEO was just granted 346,000 options and restricted shares - Jan. 9, 2018

Departure of Directors or Certain - Jan. 9, 2018

Eagle Pharmaceuticals director was just granted 10,000 options - Jan. 9, 2018

. Iridian Asset Management LLC just provided an update on share ownership of Eagle Pharmaceuticals - Jan. 8, 2018

Eagle Pharmaceuticals January 2018 - Jan. 8, 2018

. Iridian Asset Management LLC just provided an update on share ownership of Eagle Pharmaceuticals - Jan. 8, 2018

Confidential treatment order - Dec. 22, 2017

Eagle Pharmaceuticals director just picked up 2,340 shares - Dec. 20, 2017

Eagle Pharmaceuticals Just Filed Its Quarterly Report: Earnings Per Share B... - Nov. 8, 2017

Eagle Pharmaceuticals, Inc. Reports Third Quarter 2017 Results - Nov. 8, 2017

Eagle Pharmaceuticals Receives Tentative Fda Approval For Pemfexy (Pemetrexed Injection) Ready-To-Dilute - Oct. 27, 2017

Eagle Pharmaceuticals September 2017 - Sept. 26, 2017

Eagle Pharmaceuticals Licenses Japanese Rights For - Sept. 20, 2017

Eagle Pharmaceuticals September 2017 - Sept. 13, 2017

Peter S. Park just provided an update on share ownership of Eagle Pharmaceuticals - Aug. 24, 2017

Eagle Pharmaceuticals's Chief Financial Officer just picked up 350 shares - Aug. 16, 2017

Eagle Pharmaceuticals director just picked up 20,400 shares - Aug. 11, 2017

Eagle Pharmaceuticals Just Filed Its Quarterly Report: Earnings Per Share B... - Aug. 9, 2017

Eagle Pharmaceuticals, Inc. Reports Second Quarter 2017 Results - Aug. 9, 2017

Eagle Pharmaceuticals Receives Complete Response Letter From Fda On Ryanodex For Exertional Heat Stroke Application - July 26, 2017

Janus Capital Management LLC EIN just issued a filing suggesting it has sold all of its Eagle Pharmaceuticals - July 12, 2017

Janus Henderson Group plc EIN just provided an update on share ownership of Eagle Pharmaceuticals - July 7, 2017

Submission of Matters to a Vote of Security - June 23, 2017

Eagle Pharmaceuticals's Chief Financial Officer just picked up 350 shares - June 12, 2017

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. ProQuest Associates IV LLC 3,652,284 0.9 June 30, 2017
2. HENDERSON GROUP PLC 1,773,252 N/A March 31, 2019
3. JANUS CAPITAL MANAGEMENT LLC 1,454,778 0.1 March 31, 2017
4. Peter S. Park 1,260,611 N/A April 5, 2016
5. Park West Asset Management LLC 1,045,311 2.2 March 31, 2019
6. Hudson Executive Capital LP 971,000 4.5 March 31, 2019
7. BlackRock Fund Advisors 769,869 N/A Sept. 30, 2016
8. VANGUARD GROUP INC 755,573 N/A March 31, 2019
9. VANGUARD GROUP INC 755,573 N/A March 31, 2019
10. VANGUARD GROUP INC 755,573 N/A March 31, 2019
11. VANGUARD GROUP INC 755,573 N/A March 31, 2019
12. VANGUARD GROUP INC 755,573 N/A March 31, 2019
13. VANGUARD GROUP INC 755,573 N/A March 31, 2019
14. VANGUARD GROUP INC 755,573 N/A March 31, 2019
15. VANGUARD GROUP INC 755,573 N/A March 31, 2019
16. VANGUARD GROUP INC 755,573 N/A March 31, 2019
17. VANGUARD GROUP INC 755,573 N/A March 31, 2019
18. VANGUARD GROUP INC 755,573 N/A March 31, 2019
19. VANGUARD GROUP INC 755,573 N/A March 31, 2019
20. VANGUARD GROUP INC 755,573 N/A March 31, 2019
21. VANGUARD GROUP INC 755,573 N/A March 31, 2019
22. VANGUARD GROUP INC 755,573 N/A March 31, 2019
23. VANGUARD GROUP INC 755,573 N/A March 31, 2019
24. VANGUARD GROUP INC 755,573 N/A March 31, 2019
25. VANGUARD GROUP INC 755,573 N/A March 31, 2019
26. VANGUARD GROUP INC 755,573 N/A March 31, 2019
27. VANGUARD GROUP INC 755,573 N/A March 31, 2019
28. VANGUARD GROUP INC 755,573 N/A March 31, 2019
29. VANGUARD GROUP INC 755,573 N/A March 31, 2019
30. VANGUARD GROUP INC 755,573 N/A March 31, 2019

Eagle Pharmaceuticals (EGRX)

140
 


Feedback